# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 05-08-2024 | 03-31-2024 | 10-Q | |
2 | 02-28-2024 | 12-31-2023 | 10-K |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and lowers the price target from $90 to...
Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from...
HC Wainwright & Co. analyst Patrick Trucchio maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price ta...
Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.
Leerink Partners analyst Jonathan Chang initiates coverage on Immunocore Hldgs (NASDAQ:IMCR) with a Outperform rating and an...
Guggenheim analyst Michael Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $92 price target.
Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.